Clinical TrialsSearch results
Number of results: 596
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A randomized controlled phase 2 trial comparing the safety and usefulness of robot-assisted esophagectomy and thoracoscopic
- esophageal cancer and gastroesophageal junction cancer
- Takeuchi Hiroya
- 2023-02-28
Completed
- Safety Examination of Termite Extract
- None
- Tomohito Sato
- 2023-02-24
Other
- Development of the hot compress to reduce vascular pain caused by peripheral intravenous oxaliplatin administration
- Colorectal cancer,Small bowel cancer,Gastric cancer
- Iwasaki Yuko
- 2023-02-16
Completed
- Verification of Safety and Efficacy of Enoki Mushroom Extract Powder Foods in Male Menopausal Symptoms
- Normal male (healthy male)
- Ono Ken
- 2023-02-14
Completed
- A study on the relationship between subjective fatigue level before and after work and oxidative stress in forestry workers
- Relationship between workload and oxidative stress and antioxidant capacity in forestry workers.
- Odagiri Keiichi
- 2023-02-09
Other
- 10 years follow-up study of chemonucleolysis with condoliase
- Lumbar disc herniation
- Matsuyama Yukihiro
- 2023-02-02
Recruiting
- A study to learn more about asundexian (also called BAY2433334) for prevention of ischemic stroke in male and female participants aged 18 years and older who already had such a stroke due to a blood clot that formed outside the heart and travelled to the brain, or temporary stroke-like symptoms
- Acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack
- Masashi Myoishi
- 2023-02-01
No Longer Recruiting
- A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants with Advanced Cancers
- Neoplasms
- Fujikawa Ei
- 2023-01-31
Other
- Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
- Triple Negative Breast Cancer / PD-L1 Positive
- Iwahori Yuki
- 2023-01-22
Other
- Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Metastatic Triple-Negative Breast Cancer
- Triple Negative Breast Cancer / PD-L1 Negative
- Iwahori Yuki
- 2023-01-22